van Bodegraven AA - Search Results

1

Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids.

Rodrigues D, van Kampen R, van Bodegraven AA, Kleinjans JCS, Jennen DGJ, de Kok TM. Rodrigues D, et al. Among authors: van bodegraven aa, van kampen r. Toxicol Lett. 2022 Dec 1;371:17-24. doi: 10.1016/j.toxlet.2022.09.013. Epub 2022 Sep 29. Toxicol Lett. 2022. PMID: 36183961 Free article.

2

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial.

Janssen L, Romberg-Camps M, van Bodegraven A, Haans J, Aquarius M, Boekema P, Munnecom T, Brandts L, Joore M, Masclee A, Jonkers D, Pierik M. Janssen L, et al. BMJ Open. 2021 May 4;11(5):e042885. doi: 10.1136/bmjopen-2020-042885. BMJ Open. 2021. PMID: 33947729 Free PMC article.

3

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.

Crouwel F, Simsek M, de Boer MA, Mulder CJJ, van Andel EM, Creemers RH, van Asseldonk DP, van Bodegraven AA, Horjus CS, Visschedijk MC, Weusthuis ALM, Seinen ML, Jharap B, van Schaik FDM, Ahmad I, Boekema PJ, Tack GJ, Wormmeester L, Lutgens MWMD, van Boeckel PGA, Gilissen LPL, Kerkhof M, Russel MGVM, Hoentjen F, Bartelink ME, Kuijvenhoven JP, Maljaars JWJ, van Dop WA, Wonders J, van der Voorn MMPJA, Buiter HJC, de Boer NK. Crouwel F, et al. Among authors: van schaik fdm, van der voorn mmpja, van asseldonk dp, van bodegraven aa, van dop wa, van boeckel pga, van andel em. J Crohns Colitis. 2023 May 3;17(5):738-745. doi: 10.1093/ecco-jcc/jjac183. J Crohns Colitis. 2023. PMID: 36521000 Free PMC article.

4

The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.

Gilissen LPL, Tajzai R, Romberg M, Pierik M, Stronkhorst A, Steenhuisen K, Van Bodegraven A, Daniels A, Wong D. Gilissen LPL, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e102-e107. doi: 10.1097/MEG.0000000000001980. Eur J Gastroenterol Hepatol. 2021. PMID: 33136726

5

Editorial: assessment of inflammatory bowel disease-a picture is worth a thousand words.

Horjus-Talabur Horje CS, van Bodegraven AA. Horjus-Talabur Horje CS, et al. Among authors: van bodegraven aa. Aliment Pharmacol Ther. 2021 Aug;54(4):508-509. doi: 10.1111/apt.16476. Aliment Pharmacol Ther. 2021. PMID: 34331796 No abstract available.

6

Feasibility and Efficiency of the BEFORE (Better Exercise and Food, Better Recovery) Prehabilitation Program.

Tweed TTT, Sier MAT, Van Bodegraven AA, Van Nie NC, Sipers WMWH, Boerma EG, Stoot JHMB. Tweed TTT, et al. Among authors: van nie nc, van bodegraven aa. Nutrients. 2021 Oct 2;13(10):3493. doi: 10.3390/nu13103493. Nutrients. 2021. PMID: 34684494 Free PMC article.

7

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.

van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk CJ, Vermeijden JR, Siersema PD, van Oijen MG, Oldenburg B; COIN study group and the Dutch Initiative on Crohn and Colitis. van der Valk ME, et al. Among authors: van der woude cj, van oijen mg, van bodegraven aa, van de meeberg pc, van der meulen de jong ae. Gut. 2014 Jan;63(1):72-9. doi: 10.1136/gutjnl-2012-303376. Epub 2012 Nov 7. Gut. 2014. PMID: 23135759

8

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).

Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van Bodegraven AA, van der Woude CJ. Dewint P, et al. Among authors: van der woude cj, van bodegraven aa, van dullemen hm. Gut. 2014 Feb;63(2):292-9. doi: 10.1136/gutjnl-2013-304488. Epub 2013 Mar 23. Gut. 2014. PMID: 23525574 Clinical Trial.

9

Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.

van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk CJ, Vermeijden JR, Siersema PD, van Oijen MG, Oldenburg B; COIN study group; Dutch Initiative on Crohn and Colitis. van der Valk ME, et al. Among authors: van der woude cj, van oijen mg, van bodegraven aa, van de meeberg pc, van der meulen de jong ae. J Crohns Colitis. 2014 Jul;8(7):590-7. doi: 10.1016/j.crohns.2013.11.019. Epub 2013 Dec 16. J Crohns Colitis. 2014. PMID: 24351733

10

Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.

van der Have M, Fidder HH, Leenders M, Kaptein AA, van der Valk ME, van Bodegraven AA, Dijkstra G, de Jong DJ, Pierik M, Ponsioen CY, van der Meulen-de Jong AE, van der Woude CJ, van de Meeberg PC, Romberg-Camps MJ, Clemens CH, Jansen JM, Mahmmod N, Bolwerk CJ, Vermeijden JR, Siersema PD, Oldenburg B; COIN study group; Dutch Initiative on Crohn and Colitis. van der Have M, et al. Among authors: van der woude cj, van bodegraven aa, van der valk me, van de meeberg pc, van der meulen de jong ae. Inflamm Bowel Dis. 2015 Feb;21(2):369-77. doi: 10.1097/MIB.0000000000000278. Inflamm Bowel Dis. 2015. PMID: 25569738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page